Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Amdipharm Limited, Temple Chambers, 3 Burlington Road, Dublin 4, Ireland
NeoMercazole 5 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Pink, circular biconvex tablet, imprinted with “Neo 5” on the obverse and plain on the reverse. |
Each NeoMercazole 5 mg tablet contains carbimazole 5 mg.
Excipients with known effect:
Lactose monohydrate (30.0 mg/tablet)
Sucrose (139.39 mg/tablet)
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Carbimazole |
Carbimazole, a thionamide, is a pro-drug which undergoes rapid and virtually complete metabolism to the active metabolite, thiamazole, also known as methimazole. The method of action is believed to be inhibition of the organification of iodide and the coupling of iodothyronine residues which in turn suppress the synthesis of thyroid hormones. |
| List of Excipients |
|---|
|
Lactose monohydrate |
NeoMercazole 5 mg tablets are available in HDPE bottles with polypropylene tamper-evident screw cap with integrated desiccant. Each bottle contains 100 tablets.
Amdipharm Limited, Temple Chambers, 3 Burlington Road, Dublin 4, Ireland
PA1142/002/001
Date of first authorisation: 13 March 1995
Date of last renewal: 13 March 2010
| Drug | Countries | |
|---|---|---|
| NEO-MERCAZOLE | Australia, France, Ireland, New Zealand |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
